LTR Pharma (ASX:LTP) Interest Received: A$1.11 Mil (TTM As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.58
! 1 Warning Sign
View Full Analysis

What is LTR Pharma Interest Received?

LTR Pharma ASX:LTP 15 Interest Received is A$1.11 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

LTR Pharma's Interest Received for the six months ended in Dec. 2025 was A$0.51 Mil.

LTR Pharma's Interest Received for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.11 Mil.

LTR Pharma Interest Received Related Terms

LTR Pharma Interest Received Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Interest Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Interest Received Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Interest Received
0.00 0.00 0.00 0.00 0.60

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Received Get a 7-Day Free Trial 0.00 0.00 0.00 0.60 0.51
ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Interest Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Interest Received represents interest received by the company in the direct cash flow method.

Interest Received for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Received →
What does a Interest Received of A$1.11 Mil mean?
LTR Pharma (ASX:LTP) has a Interest Received of A$1.11 Mil as of Dec. 2025. Interest Received represents interest received by the company in direct cash flow method. View historical data for LTR Pharma and its competitors.
Is LTR Pharma's Interest Received too high?
LTR Pharma's current Interest Received is A$1.11 Mil. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Interest Received compare to VRTX and REGN?
LTR Pharma's Interest Received of A$1.11 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Received for a Biotechnology company?
A good Interest Received depends on the Biotechnology industry context. However, Interest Received should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Received mean?
A high Interest Received can signal that a stock is expensive relative to its fundamentals. Interest Received represents interest received by the company in direct cash flow method. View historical data for LTR Pharma and its competitors. LTR Pharma's current Interest Received is A$1.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Interest Received of A$1.11 Mil. The current Interest Received is A$1.11 Mil. LTR Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Received calculated?
Interest Received is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Interest Received is A$1.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.58
Price